Dr. Kris Talks About Defining Biomarkers

Mark G. Kris, MD, chief of the Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center discusses the importance of defining the term biomarker.

He explains that the term is too broad and can mean more than just a gene; it can be proteins, epigenetic changes, methylation changes, transcription changes, and many other kinds, narrowing in on the precise type determines the type and complexity of testing.

Dr. Kris says it's important to be precise because the complexity of the testing and the liability of the testing changes quite a bit depending on what biomarker is being looked at.